American Awareness for COVID-19

FDA-Cleared (IND #150758) C OVID-19 Therapy

UPDATE: This FDA-Cleared Study Has Expanded To African Americans and Hispanics.

Receive Free COVID Treatment Today. Qualify Below!

BREAKING NEWS: THE FREE FDA-Cleared Study You Can't Afford to Ignore!

Take The SURVEY To Find Out If You Qualify For This Breakthrough Study For African Americans & Hispanics...

BREAKING NEWS: THE FREE FDA-CLEARED STUDY YOU CAN'T AFFORD TO IGNORE!

Take The SURVEY To Find Out If You Qualify For The Breakthrough Study...

BE A DIFFERENCE MAKER FOR ALL!

Start Here..

1. Are you 18 years old or older? *

2. Have you been diagnosed with COVID-19 recently?

3. What's your age? *

4. Those with COVID-19 typically suffer from 1 or more of these issues. Which of these issues you suffer from the most? *

5. Lastly, do you live in the United States? *

Take The SURVEY To Find Out If You Qualify For The Breakthrough Study For African Americans & Hispanics...

The FIRST FDA-CLEARED STUDY Specifically HELPing AFRICAN AMERICANS & Hispanics WITH THE CORONAVIRUS

This first & only COVID-19 study was set in place to prevent the rapid progression of the virus, improve recovery and survival of Hispanics & African Americans, or anyone who is symptomatic.

Watch Dr. Harris And Dr. Bryan Discuss The Study

This is the first and only COVID-19 study specifically addressing the health disparities in African Americans & Hispanics, one of the most

affected, high-risk populations of the virus.

Plus, it’s FREE to join the study!

THE BREAKTHROUGH COVID-19 TREATMENT

NOviricid is the first oral Nitric Oxide (NO) generating drug to be clinically tested to treat African Americans & Hispanics diagnosed with COVID-19.

Recent reports from the U.S. database compiled by CDC reports mortality from COVID-19 to have a racial disparity [2]. A disproportionate number of COVID-19 fatalities among African Americans and Hispanics has been observed.

Early data coming out of China revealed patients with underlying cardiovascular disease were more susceptible to infection, greater disease severity, and a ten times higher mortality.

Hypertension is highly prevalent in African Americans & Hispanics with an association with diminished nitric oxide (NO) levels [4]
Hypertension often leads to the development of a cardiomyopathy and heart failure [5]
Additionally, there are unique manifestations to the COVID-19 disease that make African Americans & Hispanics with low NO potentially at higher risk.

This current clinical trial aims to test the efficacy of a more potent nitric oxide lozenge (30 mg sodium nitrite) on patients diagnosed with COVID-19 infection to investigate if restoring nitric oxide can prevent the progression of the disease, reduced need for ventilation, and decreased death.

Nitric oxide drug therapy will address all of the underlying risk factors for African Americans & Hispanics with COVID and protect from the long term complications of COVID, including the risk of blood clots, embolism, heart attack, and stroke.

What Is Nitric Oxide? Watch 1-Min Video

What is Nitric Oxide?

Watch 1-Min Video Above

Early data coming out of China revealed patients with underlying cardiovascular disease were more susceptible to infection, greater disease severity, and a ten times higher mortality

Hypertension is highly prevalent in Hispanics African Americans with an association with diminished nitric oxide (NO) levels [4]
Hypertension often leads to the development of a cardiomyopathy and heart failure [5]
Additionally, there are unique manifestations to the COVID-19 disease that make African Americans & Hispanics with low NO potentially at higher risk.

Nitric oxide drug therapy will address all of the underlying risk factors for Hispanics & African Americans with COVID and protect from the long term complications of COVID, including the risk of blood clots, embolism, heart attack, and stroke.

The NEW Approach To COVID...

To specifically address the health disparities in African Americans & Hispanics.

NOT another vaccine or anti-viral...

Dr. Richard Harris M.D., Pharm.D, MBA

Dr. Richard E Harris II is a board-certified internal medicine physician and pharmacist. Dr. Harris attended the University of Texas at Austin for pharmacy school then pursued medical education at the McGovern school of medicine in Houston. Dr. Harris completed his residency in Internal Medicine at UTMB in Galveston. Dr. Harris has a client-centric view focusing on building relationships and trust through a comprehensive lifestyle medicine system combined with genetic and micronutrient testing. In his spare time, he is an avid reader, weight lifter, video game enthusiast, and author. Dr. Harris also enjoys sports, traveling, philanthropy, church, and keto donuts.

Michael A. McGee, MD, MPH, FACEP.

Michael A. McGee, MD, MPH, FACEP is a compassionate, caring physician who has been practicing emergency medicine since 2004. He graduated from Purdue University where he completed a Bachelor of Science Degree in Biology/Psychology. Dr. McGee later achieved a Masters in Public Health in Epidemiology and Biostatistics from the University of Illinois in Chicago, a Medical Doctorate from Rush Medical College in Chicago, and completed his Internship and Residency in the Department of Emergency Medicine at New York University (NYU) / Bellevue Hospital Medical Center in New York, NY. Upon completion of residency, Dr. McGee worked as an Assistant Professor of Emergency Medicine at Emory/Grady Medical Center in Atlanta, Georgia. In March of 2010, he became the President and Chief Executive Officer (CEO) of an independent Methodist ER Group called Northwest Emergency Associates (NEA), LLC. Dr. McGee currently functions as the Chief and Medical Director for the Emergency Medicine Departments at Methodist Hospitals in Gary and Merrillville, Indiana, as well as, the Emergency Medical Services (EMS) Medical Director.

Dr. Byron Dean, DO

Dr. Byron Dean, DO is a Family Medicine Specialist in Lakeland, FL and has over 19 years of experience in the medical field. He graduated from Des Moines University College Of Osteopathic Medicine medical school in 2002. He is affiliated with medical facilities such as Adventhealth Orlando and Bartow Regional Medical Center.

Nathan S. Bryan, Ph.D.

Dr. Bryan earned his undergraduate Bachelor of Science degree in Biochemistry from the University of Texas at Austin and his doctoral degree from Louisiana State University School of Medicine in Shreveport where he was the recipient of the Dean’s Award for Excellence in Research. He pursued his post-doctoral training as a Kirschstein Fellow at Boston University School of Medicine in the Whitaker Cardiovascular Institute. After a two-year post-doctoral fellowship, in 2006 Dr. Bryan was recruited to join faculty at the University of Texas Health Science Center at Houston by Ferid Murad, M.D., Ph.D., 1998 Nobel Laureate in Medicine or Physiology. Dr. Bryan has made many seminal discoveries in the nitric oxide field that has resulted in over a dozen issued US and International patents. He is also a successful entrepreneur who has successfully commercialized his nitric oxide technology. Dr. Bryan has published a number of highly cited papers and authored or edited 5 books. He is an international leader in molecular medicine and nitric oxide biochemistry.

Dr. Cheng Ruan M.D .

A native Houstonian, Dr. Cheng-huai Ruan graduated from Texas A&M University in College Station and received his medical degree from Ross University School of Medicine in Dominica, West Indies. He completed his residency in internal medicine at New York-Presbyterian/Queens Hospital where he served as chief resident and was named physician mentor of the year by his peers.

Board-certified in internal medicine, Dr. Ruan specializes in the diagnosis and treatment of a broad spectrum of chronic illnesses to emergent medical care for patients 13 years and older. His clinical interests include internal medicine and diabetes. He has created a diabetes reversal program that uses food as medicine.

Fluent in Mandarin, Dr. Ruan stresses the importance of knowledge and education. He is passionate about empowering his patients to optimize their health and lower their risk of disease. A strong advocate of open patient-physician communication, Dr. Ruan is accessible through many avenues, including social media.